COGT
Cogent Biosciences, Inc.
Stock
$31.02−0.57 (−1.80%)Close Oct 2, 2026
- Research and development, 2025
- $270M
- YoY, 2025
- +16.0%
- 5-year CAGR
- +60.0%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $270M | +16.0% |
| 2024 | $233M | +33.9% |
| 2023 | $174M | +42.9% |
| 2022 | $122M | +117.5% |
| 2021 | $56M | +117.2% |
| 2020 | $26M | −41.1% |
| 2019 | $44M | +14.2% |
| 2018 | $38M | +28.3% |
| 2017 | $30M | — |